Oslo
Norway
2
2023-12-28
2
2024-09-10
These are the the leading inventors for applications assigned to SERODUS ASA:
SERODUS ASA based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Dual TNFR1 antagonists and TNER2 agonists for use in renal diseases
#2 | 2014-03-13 ✅ Patent 9,359,405 granted on 2016-06-07Antagonists of the interleukin-1 receptor
58216 ⎘